Indefinite Delivery Contract VA797P15C0037

The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Seqirus USA Inc. to supply influenza virus vaccines. Under this contract vehicle, multiple firm fixed price delivery orders were issued for vaccine doses valued between $13,975 to over $12 million each. Places of performance are Seqirus' Summit, New Jersey facility. Periods of performance span from March 2023 through October 2023. The original solicitation sought proposals to supply approximately 3.39...

The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of influenza virus vaccinations. Between June 2020 and November 2020, Seqirus was issued multiple firm fixed price delivery orders against the IDV totaling over $66 million to provide influenza virus vaccines from its Summit, New Jersey facility. The vaccinations were to support the Defense Logistics Agency's medical readiness programs and fulfill requirements...

This indefinite delivery contract issued by the Department of Veterans Affairs National Acquisition Center aims to procure influenza virus vaccines for the 2020-2021 season to support the Department of Veterans Affairs, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. The original pre-solicitation notice sought quadrivalent influenza virus vaccines in multiple dose vials and pre-filled single dose syringes for individuals over 18 years of age,...

Seqirus USA Inc. (UEI: N6U7P2B9VHS5) was awarded a multiple-award Indefinite Delivery Contract with a ceiling value of $86.5 million by the Centers for Disease Control and Prevention (CDC) to supply adult influenza vaccines through February 28, 2027. This civilian procurement, awarded December 31, 2025, supports the CDC's vaccine distribution requirements without utilization of small business set-asides. The contract represents Seqirus's established position as a critical federal vaccine...

Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer specializing in vaccine production, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs' National Acquisition Center (acting as the Civilian Funding Agency) on March 15, 2025, with a ceiling value of $113,670.50 and a performance period extending through March 14, 2026. This contract procures Influenza Virus Vaccine for the 2025-2026 flu season and incorporates a 2026 Small Business...

The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Glaxosmithkline, LLC to supply influenza virus vaccinations. Delivery orders issued against this vehicle total over $44.5 million and require Glaxosmithkline to provide vaccines from its Research Triangle Park, North Carolina facility. Performance periods range from March 2021 to November 2021. No set-asides or subcontractors are specified. This contract aims to ensure U.S. armed forces and DLA...

The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of injectable influenza virus vaccines. The potential value of the contract vehicle is $22.6 million to be delivered between February 2021 through February 2022. Several firm fixed price delivery orders were subsequently issued against this contract for vaccine quantities between $778 to $6.6 million to support the Agency's medical countermeasures programs....

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain, a defense agency, to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $6.86 million single-award IDC is for the delivery of influenza virus vaccines over the period from February 2025 to February 2026. Seqirus USA Inc. is a significant federal contractor in this space, holding several large IDCs with agencies like the Department of Veterans Affairs...

The Centers for Disease Control and Prevention awarded Seqirus USA Inc. a multiple award indefinite delivery contract with a potential value of $129.8 million to supply pediatric influenza vaccines through February 2028. Task orders will be issued against the contract to procure required vaccines annually to support the CDC's national immunization programs. As a leading manufacturer of influenza vaccines, Seqirus will deliver various formulations of pediatric flu vaccines to the CDC for...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The $143 million IDC is for the supply of adult influenza vaccines, and a separate $208 million IDC is for pediatric influenza vaccines, to support the CDC's nationwide immunization programs from 2022-2023. Seqirus USA Inc. has also been awarded several other high-value...